ZIOPHARM ONCOLOGY INC's ticker is ZIOP and the CUSIP is 98973P101. A total of 144 filers reported holding ZIOPHARM ONCOLOGY INC in Q4 2016. The put-call ratio across all filers is 1.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $56,000 | -31.7% | 10,000 | -33.3% | 0.05% | -36.2% |
| Q2 2016 | $82,000 | -26.1% | 15,000 | 0.0% | 0.08% | -28.6% |
| Q1 2016 | $111,000 | -11.2% | 15,000 | 0.0% | 0.11% | +4.7% |
| Q4 2015 | $125,000 | -7.4% | 15,000 | 0.0% | 0.11% | -9.3% |
| Q3 2015 | $135,000 | -25.0% | 15,000 | 0.0% | 0.12% | -16.3% |
| Q2 2015 | $180,000 | +11.1% | 15,000 | 0.0% | 0.14% | +6.0% |
| Q1 2015 | $162,000 | – | 15,000 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 9,709,607 | $51,946,000 | 2.80% |
| MILLER VALUE PARTNERS, LLC | 4,900,721 | $26,219,000 | 1.15% |
| MSD Partners, L.P. | 3,410,500 | $18,246,000 | 0.92% |
| Michael & Susan Dell Foundation | 66,749 | $357,000 | 0.26% |
| Glacier Peak Capital LLC | 68,043 | $364,000 | 0.21% |
| Vident Investment Advisory, LLC | 114,980 | $615,000 | 0.08% |
| SFMG, LLC | 62,433 | $334,000 | 0.07% |
| Virtus ETF Advisers LLC | 40,359 | $216,000 | 0.06% |
| Steward Partners Investment Advisory, LLC | 23,187 | $124,000 | 0.06% |
| O'Dell Group, LLC | 10,142 | $54,000 | 0.05% |